Investors Are Now Capitalizing on Growing Biotech Industry with Corporate Forum Leading The Way

Share Article

Financial experts at Corporate Forum begin to offer insight on the importance of biotechnology investments based on recent news of it's importance.

Boston Investment Group
Investors often feel drawn to the industry because of personal connections and sentiments.

The Boston Business Journal recently released an article on the growing importance of biotechnology investments in Massachusetts. The article notes that biotech investments have become major venture capital investments within the past year, and that Boston has become the center around which these deals take place.

The Boston investment group Corporate Forum, based outside of Boston, has noticed a sharp increase in newly public biotech companies that wish to meet with potential investors as these biotech companies know that they have to work hard to win the attention of the retail investment community.

Corporate Forum facilitates this interaction by arranging luncheons where biotech companies and retail investors can meet face-to-face. These luncheons provide an opportunity for the company to explain what disease is being targeted, the product that is being developed, and how much research has already been completed. Although all of this information is also available online, a Boston investors club can provide an opportunity to hear directly from the management team. This in turn can allow for a better assessment of whether the company is a good fit for the investor's portfolio.

Furthermore, as company President Beth Kurth notes, investors often feel drawn to the industry because of personal connections and sentiments. “Biotech companies connect particularly well with retail investors,” Kurth states, “because every investor knows someone who suffers from cancer, or diabetes, or another other disease that the technologies are targeting.”

Like any other investment-driven industry, biotech certainly has the potential to rise and fall. However, Kurth notes, biotech companies offer a wide range of target markets, product candidates and development stages. Investment clubs, like the meetings offered by Corporate Forum, can help investors choose which companies are the best fit for their risk/reward tolerance. And at a time when scientific discoveries are happening with greater frequency, biotechnology companies can fulfill health-related niche.

The Corporate Forum brings publicly traded companies face-to-face with the retail investment community. Founded in 1971 as the Boston Stockbrokers Club, the Corporate Forum has since expanded into other cities nationwide. Companies from all sectors and market capitalizations use our services to speak directly to this large and broad cross-section of investors. To learn more about how companies can connect with retail investors, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

James McMinn
Leap Clixx
+1 (314) 641-1000
Email >
Visit website